Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2016, ended Dec 31, 2016 | $31.0B |
| FY2017, ended Dec 31, 2017 | $36.2B |
| FY2018, ended Dec 31, 2018 | $36.9B |
| FY2019, ended Dec 31, 2019 | $46.7B |
| FY2020, ended Dec 31, 2020 | $41.4B |
| FY2021, ended Dec 31, 2021 | $44.9B |
| FY2022, ended Dec 31, 2022 | $48.8B |
| FY2023, ended Dec 31, 2023 | $42.7B |
| FY2024, ended Dec 31, 2024 | $49.2B |
| FY2025, ended Dec 31, 2025 | $62.4B |
| Trailing 12 months to Mar 31, 2026 (through Q1 FY2026) | $71.3B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2016, ended Dec 31, 2016 | $16.4B |
| FY2017, ended Dec 31, 2017 | $15.4B |
| FY2018, ended Dec 31, 2018 | $16.2B |
| FY2019, ended Dec 31, 2019 | $15.6B |
| FY2020, ended Dec 31, 2020 | $14.9B |
| FY2021, ended Dec 31, 2021 | $16.8B |
| FY2022, ended Dec 31, 2022 | $19.6B |
| FY2023, ended Dec 31, 2023 | $19.5B |
| FY2024, ended Dec 31, 2024 | $20.0B |
| FY2025, ended Dec 31, 2025 | $21.9B |
| Trailing 12 months to Mar 31, 2026 (through Q1 FY2026) | $22.3B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2016, ended Dec 31, 2016 | $611M | $4.41B |
| FY2017, ended Dec 31, 2017 | $1.91B | $4.27B |
| FY2018, ended Dec 31, 2018 | $1.92B | $5.22B |
| FY2019, ended Dec 31, 2019 | $1.92B | $3.35B |
| FY2020, ended Dec 31, 2020 | $2.20B | $3.83B |
| FY2021, ended Dec 31, 2021 | $2.49B | — |
| FY2022, ended Dec 31, 2022 | $2.31B | — |
| FY2023, ended Dec 31, 2023 | $2.21B | $4.86B |
| FY2024, ended Dec 31, 2024 | $2.97B | $6.41B |
| FY2025, ended Dec 31, 2025 | $3.58B | $3.49B |
| Trailing 12 months to Mar 31, 2026 (through Q1 FY2026) | $3.65B | $2.60B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2016, ended Dec 31, 2016 | $211M |
| FY2017, ended Dec 31, 2017 | $215M |
| FY2018, ended Dec 31, 2018 | $234M |
| FY2019, ended Dec 31, 2019 | $247M |
| FY2020, ended Dec 31, 2020 | $393M |
| FY2021, ended Dec 31, 2021 | $403M |
| FY2022, ended Dec 31, 2022 | $509M |
| FY2023, ended Dec 31, 2023 | $330M |
| FY2024, ended Dec 31, 2024 | $203M |
| FY2025, ended Dec 31, 2025 | $197M |
| Trailing 12 months to Mar 31, 2026 (through Q1 FY2026) | $306M |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2016, ended Dec 31, 2016 | $22.0B |
| FY2017, ended Dec 31, 2017 | $22.8B |
| FY2018, ended Dec 31, 2018 | $25.3B |
| FY2019, ended Dec 31, 2019 | $29.6B |
| FY2020, ended Dec 31, 2020 | $33.6B |
| FY2021, ended Dec 31, 2021 | $36.1B |
| FY2022, ended Dec 31, 2022 | $40.9B |
| FY2023, ended Dec 31, 2023 | $43.0B |
| FY2024, ended Dec 31, 2024 | $45.2B |
| FY2025, ended Dec 31, 2025 | $48.8B |
| Trailing 12 months to Mar 31, 2026 (through Q1 FY2026) | $51.1B |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Up 10.7% since FY16.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2016, ended Dec 31, 2016 | 492M |
| FY2017, ended Dec 31, 2017 | 492M |
| FY2018, ended Dec 31, 2018 | 493M |
| FY2019, ended Dec 31, 2019 | 494M |
| FY2020, ended Dec 31, 2020 | 497M |
| FY2021, ended Dec 31, 2021 | 504M |
| FY2022, ended Dec 31, 2022 | 514M |
| FY2023, ended Dec 31, 2023 | 526M |
| FY2024, ended Dec 31, 2024 | 533M |
| FY2025, ended Dec 31, 2025 | 541M |
| Trailing 12 months to Mar 31, 2026 (through Q1 FY2026) | 544M |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Paid to employees | Sold for cash |
|---|---|---|
| FY2016, ended Dec 31, 2016 | — | $34.2M |
| FY2017, ended Dec 31, 2017 | — | $12.2M |
| FY2018, ended Dec 31, 2018 | — | $73.6M |
| FY2019, ended Dec 31, 2019 | — | $65.3M |
| FY2020, ended Dec 31, 2020 | — | $155M |
| FY2021, ended Dec 31, 2021 | — | $601M |
| FY2022, ended Dec 31, 2022 | $63.3M | $827M |
| FY2023, ended Dec 31, 2023 | $51.0M | $1.00B |
| FY2024, ended Dec 31, 2024 | $53.0M | $552M |
| FY2025, ended Dec 31, 2025 | $53.0M | $775M |
| Trailing 12 months to Mar 31, 2026 (through Q1 FY2026) | — | $1.06B |
Valuation
At current price- Market Cap
- $70.9B
- P/E
- 19.4×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 3.2×
- Price / Book
- 2.2×
- EV / EBITDA
- —. (Market cap + debt − cash) / EBITDA (TTM)
Growth
Trailing 12 months- Revenue (TTM)
- $22.3B
- Revenue Growth YoY
- 8.5%
- Revenue CAGR 3Y
- 3.7%
- Revenue CAGR 5Y
- 8.0%
- EPS Growth YoY
- 30.5%
- Net Income Growth YoY
- 32.3%
Profitability
Trailing 12 months- Gross Margin
- —
- Operating Margin
- 24.2%
- Net Margin
- 16.4%
- FCF Margin
- 11.7%
- Return on Equity
- 12.4%
Earnings
Trailing 12 months- Net Income
- $3.65B
- EPS (diluted)
- $6.76
- EBITDA
- —. Operating income + depreciation & amortization
- Operating Income
- $5.39B
Balance Sheet
As of Mar 31, 2026- Cash and cash equivalents
- $306M
- Total Debt
- $51.1B
- Net Debt
- $50.8B
- Total Assets
- $118B
- Total Liabilities
- $84.7B
- Shareholders' Equity
- $31.8B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $7.01B
- Capital Expenditure
- $4.42B
- Free Cash Flow
- $2.60B
Dividends and risk
Last 12 months- Dividend Yield
- 2.9%
- Dividend / Share
- $3.80
- Beta (5Y)
- 0.48
Every ratio is calculated from the company’s reported figures.